ARK Invest's position in INMD, updated every trading day. Data as of 2026-11-12.
| Fund | Shares | Value | Weight | Rank |
|---|---|---|---|---|
| IZRL | 133,663 | $1.8M | 1.47% | #43 |
| Trade day | Fund | Side | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-12 | IZRL | Sell | Trimmed | 5,807 | $77K |
| 2026-10-16 | IZRL | Buy | Added | 3,675 | $52K |
| 2026-07-16 | IZRL | Sell | Trimmed | 12,322 | $192K |
| 2026-04-16 | IZRL | Sell | Trimmed | 4,502 | $65K |
| 2026-01-15 | IZRL | Buy | Added | 18,205 | $256K |
| 2025-10-17 | IZRL | Sell | Trimmed | 1,673 | $26K |
| 2025-10-16 | IZRL | Sell | Trimmed | 8,033 | $122K |
| 2025-07-18 | IZRL | Buy | Added | 1,642 | $23K |
| 2025-07-17 | IZRL | Buy | Added | 32,319 | $456K |
| 2025-04-17 | IZRL | Buy | Added | 2,615 | $39K |
| 2025-01-16 | IZRL | Buy | Added | 21,228 | $352K |
| 2024-12-04 | IZRL | Sell | Trimmed | 968 | $19K |
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body…
See INMD's full ARK history since 2024, ARK's estimated cost basis, the conviction score and buy/sell alerts.
Open INMD on FundWake →Data comes from ARK Invest's public daily holdings and trade files. FundWake is not affiliated with ARK Invest. Nothing here is investment advice.